Cat.#: ACPP-1572
Despition | AIF1 Human Recombinant |
SIZE | 2 µg |
Purity | > 90% (SDS-PAGE) |
Form | Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1741 | Human NDRG1 Protein (AC1741) | 10 µg | inquiry |
ACPP-1709 | Human GPC4 Protein (AC1709) | 2 µg | inquiry |
ACPP-1257 | MC4 Receptor Blocking Peptide (AC1257) | 250 µg | inquiry |
ACPP-1429 | Human FGF14 Protein (AC1429) | 2 µg | inquiry |
ACPP-1433 | Human Interleukin 6 (Active) Protein (AC1433) | 100 µg | inquiry |
ACPP-1145 | Recombinant Mouse CD34 Protein (Fc Tag) (AC1145) | 50 µg | inquiry |
ACPP-1813 | Human HAAO Protein (AC1813) | 5 µg | inquiry |
ACPP-1138 | Recombinant Human Semaphorin 7a Protein (6×His Tag) (AC1138) | 50 µg | inquiry |
ACPP-1786 | Human FGF 1 Protein (AC1786) | 10 µg | inquiry |
ACPP-1291 | FGFR1 Blocking Peptide (AC1291) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.